Bitcoin started September bleeding, falling 6.5% just as older wallets began emptying fast. On Friday, nearly 97,000 BTC was pushed out by long-term holders, the largest one-day dump of the year, according to Glassnode. The entire surge came from coins that had been sitting tight for anywhere between six months and five years. That’s what […]Bitcoin started September bleeding, falling 6.5% just as older wallets began emptying fast. On Friday, nearly 97,000 BTC was pushed out by long-term holders, the largest one-day dump of the year, according to Glassnode. The entire surge came from coins that had been sitting tight for anywhere between six months and five years. That’s what […]

Bitcoin drops 6.5% as old wallets dump, corporates keep buying

Bitcoin started September bleeding, falling 6.5% just as older wallets began emptying fast. On Friday, nearly 97,000 BTC was pushed out by long-term holders, the largest one-day dump of the year, according to Glassnode.

The entire surge came from coins that had been sitting tight for anywhere between six months and five years. That’s what sent the 14-day simple moving average (SMA) for long-term spending climbing.

Wallets holding coins for 1 to 2 years let go of 34,500 BTC. Another 16,600 BTC came from the 6 to 12-month range, and the 3 to 5-year-old wallets dumped 16,000 BTC.

That’s over 70% of the total sell volume from just three age groups. All that Bitcoin hit the market just as prices dropped to $108,000 Friday afternoon. But by Monday, it bounced back to over $109,000.

Bitcoin enters September 6.5% down as long term holder activity surgesSource: Glassnode

Companies keep stacking while Bitcoin trades lower

Even with the price dip, Bitcoin is still up more than 17% for the year. But price isn’t the headline anymore. What matters is who’s buying. This year’s real story is corporate. Both private and public companies have been loading up their treasuries with Bitcoin, and that trend just got louder.

The model came straight from Michael Saylor, whose firm, Strategy (MSTR), formerly known as MicroStrategy, was the first to throw corporate weight behind the asset.

Now, that playbook has been copied by at least 180 other firms. And of those, around 25% were trading below the value of their Bitcoin holdings as of August 22, based on data from Capriole Investments. The situation’s getting strange enough that buying shares in these companies is basically buying cheap Bitcoin, sometimes cheaper than market price.

In July, public companies alone bought up nearly two-thirds of all the Bitcoin acquired by major players—ETPs, governments, corporates, everybody.

Nikolaos Panigirtzoglou, Managing Director at JPMorgan, said the effect of these new buyers is already being felt. He believes this wave could make Bitcoin “more attractive from a valuation point of view,” adding that falling volatility may even make it a stronger challenger to gold. The steadier the buying, the more likely Bitcoin is to keep showing up in portfolios that used to only hold metals and fiat.

Corporate treasuries are also holding Ether, and even smaller names are getting attention. Just last week, Trump Media Group announced it would partner with Crypto.com to launch Trump Media Group CRO Strategy. That company will manage Cronos (CRO-USD), Crypto.com’s in-house blockchain token. Since the Tuesday announcement, CRO’s market cap has jumped to $9 billion.

The buying surge and political greenlight are unfolding while the U.S. economy sits in the shadow of quantitative easing. The Fed used it during COVID and the 2008 crash, pumping the economy with money to avoid collapse. Critics have long called it “money printing,” warning it fuels risky behavior and pushes bubbles higher.

Your crypto news deserves attention - KEY Difference Wire puts you on 250+ top sites

Market Opportunity
SIX Logo
SIX Price(SIX)
$0.01211
$0.01211$0.01211
-0.90%
USD
SIX (SIX) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23